Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...

Disparities in delayed diagnosis, access to treatment, and treatment delays among Hispanic men with metastatic prostate cancer. Adjusted and unadjusted rates of use of molecular diagnostics and ...

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

In the field of cancer diagnostics, early detection through screening programs with highly sensitive and extremely specific cancer diagnostic protocols has supported accurate and appropriate therapy ...

Next on tap for Meridian Bioscience‘s (NASDAQ:VIVO) illumigene molecular diagnostic testing platform is a test for Mycoplasma pneumonia, an infection of the lungs. The illumigene Mycoplasma test is ...

SALT LAKE CITY, Sept. 5, 2024 /PRNewswire/ -- Co-Diagnostics (CODX), Inc. (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic ...